Biotech · Private company
TearSolutions, Inc.
Track this companyFree. Adds TearSolutions, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- 0.005% LacripepPhase 2 · Primary Sjögren SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- 0.01% LacripepPhase 2 · Primary Sjögren SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- LacripepPhase 2 · Neurotrophic KeratitisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle Ophthalmic SolutionPhase 2 · Neurotrophic KeratitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic KeratitisPHASE2 · RECRUITING · started Feb 19, 2026ClinicalTrials.gov NCT07568730 · fetched Nov 12, 2026
- Lacripep for Corneal Wound Healing StudyPHASE2 · RECRUITING · started May 23, 2025ClinicalTrials.gov NCT06854393 · fetched Nov 12, 2026
- Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's SyndromePHASE1_PHASE2 · COMPLETED · started Jun 30, 2017ClinicalTrials.gov NCT03226444 · fetched Nov 12, 2026